ENOV Stock Analysis: Buy, Sell, or Hold?
ENOV - Enovis Corporation
$26.06
-0.12 (-0.46%)
▼
5d:
+0.0%
30d:
+0.0%
90d:
+5.98%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ENOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ENOV shows positive signals but monitor for confirmation. Market pricing in 0.0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: ENOV shows positive signals but monitor for confirmation. Market pricing in 0.0% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.80
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$22.85
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ENOV is currently trading at $26.06, which is considered slightly low relative to its 30-day fair value range of $25.10 to $29.05. The stock's valuation (Forward PE: 6.5) is in line with its historical norms (6.5). At these levels, the market is pricing in -0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ENOV is in a uptrend. Immediate support is located at $23.62, while resistance sits at $27.46.
Market Sentiment: ENOV scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $40.83 (+56.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ENOV is in a uptrend. Immediate support is located at $23.62, while resistance sits at $27.46.
Market Sentiment: ENOV scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $40.83 (+56.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$25.10 -
$29.05
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 56.7% below Wall St target ($40.83)
- NEUTRAL: Market pricing in -0.0% annual earnings growth - fairly valued
- BULLISH: Bottoming setup score 64/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$25.10 -
$29.05
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$23.63
Resistance Level
$27.46
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.49
Wall Street Target
$40.83
(+56.7%)
Revenue Growth (YoY)
3.2%
Earnings Growth (YoY)
153.1%
Profit Margin
-48.0%
PE vs Historical
6.5 vs 6.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
0%
(market-implied from PE analysis)
1-Year Target
$26.06
(0%)
2-Year Target
$26.06
(0%)
3-Year Target
$26.06
(0%)
3-Yr Target (if PE normalizes)
(PE: 6→7)
$26.09
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 10.3%)
$108.03
(+315%)
Base:
(SPY PE: 6.5, Growth: 10.3%)
$34.95
(+34%)
Bear:
(PE: 5.5, Growth: 10.3%)
$29.71
(+14%)
Share & Embed Analysis
Last updated: August 22, 2026 1:54 PM ET
Data refreshes hourly during market hours. Next update: 2:54 PM
Data refreshes hourly during market hours. Next update: 2:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENOV showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Oliver Engert
BUY
1000 shares
2026-03-13
Oliver Engert
BUY
1000 shares
2026-03-09
Oliver Engert
BUY
750 shares
2026-03-06
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |
